---
figid: PMC3964016__aps2012140f1
figlink: /pmc/articles/PMC3964016/figure/fig1/
number: Figure 1
caption: 'Cl− channels and proposed functions in vascular smooth muscle cells. Cl−
  channels and their corresponding molecular candidate genes and cellular functions
  are indicated. CFTR, cystic fibrosis transmembrane conductance regulator, encodes
  Cl− channels activated by stimulation of cAMP-protein kinase A (PKA) pathway (ICl,
  PKA), protein kinase C (PKC) (ICl, PKC), or extracellular ATP through purinergic
  receptors (ICl, ATP). CFTR is composed by two membrane spanning domains (MSD1 and
  MSD2), two nucleotide binding domains (NBD1 and NBD2) and a regulatory subunit (R).
  Gi, heterodimeric inhibitory G protein; A1R, adenosine type 1 receptor; AC, adenylyl
  cyclase; H2R, histamine type II receptor; Gs, heterodimeric stimulatory G protein;
  α-AR, α-adrenergic receptor; β-AR, β-adrenergic receptor; P2R, purinergic type 2
  receptor; P, phosphorylation sites for PKA and PKC; PP, serine-threonine protein
  phosphatases. ICl, Ca is a Cl− current activated by increased intracellular Ca2+
  concentration ([Ca2+]i); Molecular candidates for ICl, Ca include TMEM16A (transmembrane
  protein 16A), the Bestrophin gene family and CLCA1, a member of a Ca2+-sensitive
  Cl− channel family (CLCA). CLC-3, a member of voltage-gated CLC Cl− channel family,
  encodes Cl− channels that are volume-regulated (ICl, vol) and can be activated by
  cell swelling (ICl, swell) induced by exposure to hypotonic extracellular solutions
  or possibly membrane stretch. ICl, b is a basally-activated CLC-3 Cl− current. Membrane
  topology model (α-helices a-r) for CLC-3 is modified from Dutzler et alCLC-3 proteins
  are expressed on both sarcolemmal membrane and intracellular organelles including
  mitochondria (mito) and endosomes. The proposed model of endosome ion flux and function
  of Nox1 and CLC-3 in the signaling endosome is adapted from Miller Jr et al. Binding
  of IL-1β or TNF-α to the cell membrane initiates endocytosis and formation of an
  early endosome (EEA1 and Rab5), which also contains NADPH oxidase subunits Nox1
  and p22phox, in addition to CLC-3. Nox1 is electrogenic, moving electrons from intracellular
  NADPH through a redox chain within the enzyme into the endosome to reduce oxygen
  to superoxide. CLC-3 functions as a chloride–proton exchanger, required for charge
  neutralization of the electron flow generated by Nox1. The ROS generated by Nox1
  result in NF-κB activation. Both CLC-3 and Nox1 are necessary for generation of
  endosomal ROS and subsequent NF-κB activation by IL-1β or TNF-α in VSMCs. Statins
  block CLC-3 channels, which causes hyperpolarization of the cell membrane, closure
  of Ca2+ channels and vasorelaxation, and inhibition of cell proliferation. Nox:
  NADPH oxidase.'
pmcid: PMC3964016
papertitle: Chloride channels in stroke.
reftext: Ya-ping Zhang, et al. Acta Pharmacol Sin. 2013 Jan;34(1):17-23.
pmc_ranked_result_index: '228297'
pathway_score: 0.9109837
filename: aps2012140f1.jpg
figtitle: Cl− channels and proposed functions in vascular smooth muscle cells
year: '2013'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3964016__aps2012140f1.html
  '@type': Dataset
  description: 'Cl− channels and proposed functions in vascular smooth muscle cells.
    Cl− channels and their corresponding molecular candidate genes and cellular functions
    are indicated. CFTR, cystic fibrosis transmembrane conductance regulator, encodes
    Cl− channels activated by stimulation of cAMP-protein kinase A (PKA) pathway (ICl,
    PKA), protein kinase C (PKC) (ICl, PKC), or extracellular ATP through purinergic
    receptors (ICl, ATP). CFTR is composed by two membrane spanning domains (MSD1
    and MSD2), two nucleotide binding domains (NBD1 and NBD2) and a regulatory subunit
    (R). Gi, heterodimeric inhibitory G protein; A1R, adenosine type 1 receptor; AC,
    adenylyl cyclase; H2R, histamine type II receptor; Gs, heterodimeric stimulatory
    G protein; α-AR, α-adrenergic receptor; β-AR, β-adrenergic receptor; P2R, purinergic
    type 2 receptor; P, phosphorylation sites for PKA and PKC; PP, serine-threonine
    protein phosphatases. ICl, Ca is a Cl− current activated by increased intracellular
    Ca2+ concentration ([Ca2+]i); Molecular candidates for ICl, Ca include TMEM16A
    (transmembrane protein 16A), the Bestrophin gene family and CLCA1, a member of
    a Ca2+-sensitive Cl− channel family (CLCA). CLC-3, a member of voltage-gated CLC
    Cl− channel family, encodes Cl− channels that are volume-regulated (ICl, vol)
    and can be activated by cell swelling (ICl, swell) induced by exposure to hypotonic
    extracellular solutions or possibly membrane stretch. ICl, b is a basally-activated
    CLC-3 Cl− current. Membrane topology model (α-helices a-r) for CLC-3 is modified
    from Dutzler et alCLC-3 proteins are expressed on both sarcolemmal membrane and
    intracellular organelles including mitochondria (mito) and endosomes. The proposed
    model of endosome ion flux and function of Nox1 and CLC-3 in the signaling endosome
    is adapted from Miller Jr et al. Binding of IL-1β or TNF-α to the cell membrane
    initiates endocytosis and formation of an early endosome (EEA1 and Rab5), which
    also contains NADPH oxidase subunits Nox1 and p22phox, in addition to CLC-3. Nox1
    is electrogenic, moving electrons from intracellular NADPH through a redox chain
    within the enzyme into the endosome to reduce oxygen to superoxide. CLC-3 functions
    as a chloride–proton exchanger, required for charge neutralization of the electron
    flow generated by Nox1. The ROS generated by Nox1 result in NF-κB activation.
    Both CLC-3 and Nox1 are necessary for generation of endosomal ROS and subsequent
    NF-κB activation by IL-1β or TNF-α in VSMCs. Statins block CLC-3 channels, which
    causes hyperpolarization of the cell membrane, closure of Ca2+ channels and vasorelaxation,
    and inhibition of cell proliferation. Nox: NADPH oxidase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY6
  - LAMA1
  - NOX1
  - ADCY8
  - NFKB1
  - IL1R1
  - ADCY5
  - CLCA1
  - AR
  - PRKACA
  - PRKD3
  - ADCY7
  - EEA1
  - IL1A
  - ADCY3
  - PRKACB
  - RAB5A
  - ADCY9
  - IL1B
  - PRKAR1B
  - PRKCH
  - PRKCI
  - ADCY10
  - PRKCZ
  - PRKAR2B
  - CLCN3
  - PRKCQ
  - ADCY4
  - CFTR
  - ADCY1
  - RAC1
  - PRKAR1A
  - PRKAR2A
  - PRKCB
  - PRKCG
  - PRKACG
  - PRKCA
  - ADCY2
  - PRKCE
  - CAMK2B
  - PRKCD
genes:
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: lama
  symbol: LAMA
  source: hgnc_prev_symbol
  hgnc_symbol: LAMA1
  entrez: '284217'
- word: Nox1
  symbol: NOX1
  source: hgnc_symbol
  hgnc_symbol: NOX1
  entrez: '27035'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: CLCA1(?)
  symbol: CLCA1
  source: hgnc_symbol
  hgnc_symbol: CLCA1
  entrez: '1179'
- word: A,R
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: EEA1
  symbol: EEA1
  source: hgnc_symbol
  hgnc_symbol: EEA1
  entrez: '8411'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Rab5
  symbol: RAB5
  source: hgnc_prev_symbol
  hgnc_symbol: RAB5A
  entrez: '5868'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: CLC-3
  symbol: ClC-3
  source: hgnc_alias_symbol
  hgnc_symbol: CLCN3
  entrez: '1182'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: CFTR
  symbol: CFTR
  source: hgnc_symbol
  hgnc_symbol: CFTR
  entrez: '1080'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: CaMKII
  symbol: CAMK2
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
chemicals: []
diseases: []
---
